170805 ⎘
Detection or diagnosis of diseases; Gastro-intestinal diseases Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
EXAMINATION METHOD FOR IMMUNE-RELATED ADVERSE EVENT ENTERITIS
#2PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING
#3COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASE
#4COMPOSITIONS, DEVICES, AND METHODS OF CROHN'S DISEASE SENSITIVITY TESTING
#5MICROBIAL METABOLITES ON INTESTINAL INFLAMMATION
#6METHODS FOR ASSESSING MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE PATIENTS
#7SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
#8ASSESSMENT OF INTESTINAL BARRIER FUNCTION TO IMPROVE TREATMENT OF INFLAMMATORY BOWEL DISEASE
#9ULCERATIVE COLITIS TREATMENTS IN SELECTED PATIENTS
#10METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
#11MICROBIOME BIOMARKERS FOR IRRITABLE BOWEL DISEASE (IBD)
#12METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST
#13Proteins and T-Cells Involved in Chronic Inflammatory Diseases
#14TARGETED DEFA5 ANTIBODY AND ASSAY METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
#15METHODS OF DIAGNOSING IBS-D AND SELECTION OF IBS-D TREATMENT
#16CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#17Methods and Apparatus for Determination of Sensitivity to Wheat
#18Method for detecting and subtyping inflammatory intestinal diseases
#19METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
#20ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS
#21DEVELOPMENT OF MICROBIAL BIOSENSORS FOR INTESTINAL INFLAMMATION
#22METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN
#23METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#24COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASE
#25ANTI-IL-23P19 ANTIBODY REGULATION OF GENES INVOLVED IN BOWEL URGENCY IN ULCERATIVE COLITIS
#26DAILY FASTING METHANE TO DETECT INTESTINAL METHANOGEN OVERGROWTH AND MONITOR TREATMENT RESPONSE
#27BIOMARKERS FOR ASSESSING THE RESPONSE STATUS FOR TREATMENT OF INFLAMMATORY CONDITION OR DISEASE AFFECTING THE DIGESTIVE TRACT SUCH AS INFLAMMATORY BOWEL DISEASE IN HUMAN PATIENTS
#28VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
#29ANTI-POLYUBIQUITIN MULTISPECIFIC ANTIBODIES
#30BIOCHIP SENSOR FOR DETECTING OF MOLECULES
#31ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE
#32IMMUNOTHERAPY FOR INFLAMMATORY BOWEL DISEASE AND/OR CANCER
#33COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS
#34METHODS FOR ASSESSING MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE PATIENTS
#35PATIENT SELECTION METHODS AND KITS FOR THERAPIES TARGETING TL1A
#36ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
#37INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#38Methods for Detecting and Treating Irritable Bowel Syndrome
#39METHODS OF PREDICTING RESPONSE TO ANTI-TNF BLOCKADE IN INFLAMMATORY BOWEL DISEASE
#40TREATMENT AND DETECTION METHODS FOR INFLAMMATORY BOWEL DISEASE
#41ANTI-MICROBIAL PEPTIDE (AMP) SIGNATURES FOR DIAGNOSTICS, STRATIFICATION, AND TREATMENT OF MICROBIOME-ASSOCIATED DISEASE
#42Detection, Treatment, and Monitoring of Microbiome-Dependent Gastrointestinal Discomfort
#43Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof
#44ANTI-MICROBIAL ANTIBODY SIGNATURES OF INFLAMMATORY BOWEL DISEASE AND USES THEREOF
#45METHODS OF MONITORING INFLAMMATORY BOWEL DISEASES
#46Cholesterol reducing compositions and methods of use thereof
#47BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS
#48METHODS FOR SYSTEMATICALLY ASSESSING LOCAL INFLAMMATION AND ACTIVE REPAIR
#49Biomarker of Fibrosis
#50COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING
#51COMPOSITIONS AND METHODS FOR PREVENTING, DETECTING, AND TREATING INFLAMMATORY BOWEL DISEASE
#52METHODS AND COMPOSITIONS FOR THE TREATMENT OF CROHN'S DISEASE
#53ANTI-METHANOGENIC LOVASTATIN ANALOGS OR DERIVATIVES AND USES THEREOF
#54METABOLIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE
#55ASSESSMENT OF INTESTINAL BARRIER FUNCTION TO IMPROVE TREATMENT OF INFLAMMATORY BOWEL DISEASE
#56METHODS AND SYSTEMS FOR STRATIFYING INFLAMMATORY BOWEL DISEASE PATIENTS
#57METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
#58TREATMENTS FOR GASTROINTESTINAL DISORDERS
#59Methods for assessing risk of developing a viral disease using a genetic test
#60Systems and methods for diagnosing and/or monitoring disease
#61METHOD OF ASSISTING DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE
#62INFLAMMATORY BOWEL DISEASE DIAGNOSIS METHOD
#63DETECTION METHOD USING EUKARYOTIC CELLS
#64Compositions and methods to detect gastrointestinal disease
#65METHOD OF DIAGNOSING A DYSBIOSIS
#66METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#67MITIGATION AND REVERSAL OF INTESTINAL FIBROSIS AND INFLAMMATION BY INHIBITION OF TL1A FUNCTION
#68METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION
#69ANTI-MAA LMMUNOGLOBULIN ISOTYPES IN INFLAMMATORY BOWEL DISEASE: NOVEL DIAGNOSTIC IMPLICATIONS FOR ULCERATIVE COLITIS
#70TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME
#71METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#72Compositions and methods to detect gastrointestinal disease
#73METHODS AND COMPOSITIONS FOR TREATING ULCERATIVE COLITIS
#74Method of Diagnosing and Treatment Monitoring of Crohn's Disease and Ulcerative Colitis
#75Biomarker For Diagnosing Johne's Disease Comprising Alpha-2-Macroglobulin And Uses Thereof
#76THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE
#77PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATHWAY BIOMARKERS
#78Methods for diagnosing and treating inflammatory bowel disease
#79Signature of TL1A (TNFSF15) signaling pathway
#80USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#81BIOMARKERS FOR IRRITABLE BOWEL SYNDROME
#82METHODS OF MONITORING MUCOSAL HEALING
#83Methods for Predicting Treatment Response in Ulcerative Colitis
#84Diagnosis and treatment of inflammatory bowel disease
#85INFLAMMATORY BOWEL DISEASE DIAGNOSIS METHOD, DIAGNOSIS PROBE AND DIAGNOSIS KIT
#86Patient Populations Amenable to IL23-Antagonist Therapy
#87IMMUNITY MECHANISM AND THERAPEUTIC DRUG FOR GASTROINTESTINAL DISEASES
#88METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL DISORDERS
#89MATERIALS AND METHODS FOR DETERMINING CANCER RISK
#90Type XXIII Collagen Assay
#91Use of Reagent for Detecting Expression Level of Transferrin in Preparation of Diagnostic Reagent or Kit for Disease Caused by Imbalance of Intestinal Immune Tolerance
#92USES OF PATIENT-DERIVED INTESTINAL ORGANOIDS FOR CELIAC DISEASE DIAGNOSIS SCREENING AND TREATMENT
#93METHOD OF DETERMINING THE PROBABILITY OF INFLAMMATORY BOWEL DISEASE IN A SUBJECT BEING ULCERATIVE COLITIS OR CROHN'S DISEASE
#94EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
#95METHODS OF DIAGNOSING DISEASE
#96METHODS OF DIAGNOSING INFLAMMATORY BOWEL DISEASE THROUGH RNASET2
#97Kit comprising contiguous nucleobases, including position 76, of RS5745994
#98CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#99COMPANION DIAGNOSTIC METHOD FOR USE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIETARY INTERVENTIONS OR FAECAL MICROBIOTA TRANSPLANT
#100Treatments for Gastrointestinal Disorders
#101Systems and methods for diagnosing and/or monitoring disease
#102METHODS OF DISEASE ACTIVITY PROFILING FOR PERSONALIZED THERAPY MANAGEMENT
#103TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
#104Methods for assessing mucosal healing in ulcerative colitis disease patients
#105Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#106ASSAY DETECTION METHODS FOR VCAM-1 AND CALPROTECTIN
#107Fluid actuation of instruments through a sterile barrier
#108BLOOD-BASED SIGNATURES FOR DIAGNOSIS AND SUB-TYPING OF INFLAMMATORY BOWEL DISEASE SUBSETS
#109METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST
#110Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#111Method for determining likelihood of an inflammatory gastrointestinal tract disease
#112DYSREGULATION OF COVID-19 RECEPTOR ASSOCIATED WITH IBD
#113Cell atlas of the healthy and ulcerative colitis human colon
#114Dosage regimen for MAdCAM antagonists
#115Compositions and methods for profiling of gut microbiota-associated bile salt hydrolase (BSH) activity
#116Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#117Targeted HD5 antibody and assay methods for diagnosing and treating inflammatory bowel disease
#118GUT MICROBIOME FUNCTION PREDICTS RESPONSE TO ANTI-INTEGRIN BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASES
#119FLUID ACTUATION OF INSTRUMENTS THROUGH A STERILE BARRIER
#120Methods for prognosing crohn's disease comprising human defensin 5 (HD5)
#121DIAGNOSIS, PROGNOSIS AND TREATMENT OF A DISEASE RELATED TO A DECREASE OF F. PRAUSNITZII
#122nAChR-alpha7 Agonists and nAChR-alpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD)
#123COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING
#124LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#125Cholesterol reducing compositions and methods of use thereof
#126HISTOLOGY GUIDED MASS SPECTROMETRY
#127Single Immunoglobulin Interleukin-1 Receptor Related (SIGIRR) Variants And Uses Thereof
#128Methods and compositions for the treatment of an inflammatory bowel disease
#129Transcutaneous organ function measurement
#130Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
#131Method of treating inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) or gluten hypersensitivity by administering an elastase 2A (ELA2A) inhibitor
#132Treatments for Gastrointestinal Disorders
#133Methods and products for evaluating an immune response to a therapeutic protein
#134Anti-methanogenic lovastatin analogs or derivatives and uses thereof
#135Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
#136Method for determining the distinctive nutritional requirements of a patient
#137Diagnosis and treatment of autoimmune diseases
#138Hydraulic instrument drive system for minimally invasive surgery
#139METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#140GUT BACTERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND METHODS THEREWITH IN DETECTING ILEAL FIBROSIS
#141METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#142USE OF GLYCANS AND GLYCOSYLTRANSFERASES FOR DIAGNOSING/MONITORING INFLAMMATORY BOWEL DISEASE
#143DIAGNOSIS OF CROHN'S DlSEASE AND ULCERATIVE COLITIS
#144Methods for detecting post-infectious irritable bowel syndrome
#145DIAGNOSIS AND TREATMENT OF MOTILITY DISORDERS OF THE GUT AND BLADDER, AND OF FIBROMYALGIA
#146ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
#147Methods for assessing mucosal healing in Crohn's disease patients
#148CCL20 as a predictor of clinical response to IL23-antagonists
#149THERAPEUTIC TREM-1 PEPTIDES
#150Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
#151METHODS FOR MONITORING VEDOLIZUMAB TREATMENT
#152COMPOSITIONS AND METHODS FOR TREATING SUBJECTS WITH IMMUNE-MEDIATED DISEASES
#153Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease
#154CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#155Signature of TL1A (TNFSF15) signaling pathway
#156DEVELOPMENT OF MICROBIAL BIOSENSORS FOR INTESTINAL INFLAMMATION
#157MARKERS FOR DISEASE AND DISEASE EXTENT IN INFLAMMATORY BOWEL DISEASE
#158Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
#159Biomarkers for assessing the response status for treatment of Inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patients
#160Method of diagnosing a dysbiosis
#161Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease
#162METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
#163Methods for prediction of anti-TNF α drug levels and autoantibody formation
#164Diagnosis and treatment of inflammatory bowel disease
#165Methods for diagnosing and treating inflammatory bowel disease
#166USE OF THE RHO GDP DISSOCIATION INHIBITOR 2 PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INTESTINAL INFLAMMATORY DISEASES
#167Method and system for detection of mycobacteria in human samples
#168Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#169MEASUREMENT OF HYDROGEN SULFIDE DURING BREATH TESTING
#170METHODS AND APPARATUS FOR DETECTION OF GLUTEN SENSITIVITY, AND ITS DIFFERENTIATION FROM CELIAC DISEASE
#171Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
#172Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript
#173ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE
#174METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#175Vedolizumab for the treatment of fistulizing Crohn's disease
#176USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#177Nanoparticles adsorbed with gliadin molecules
#178Detecting Gluten Peptides in Human Fluids
#179Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment
#180TREATING RESPIRATORY CONDITIONS
#181Pre-assembled, protected, chemically stable, chemoselective linkers
#182Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#183Biomarker test and method for assessing mucosal healing in response to treatment of ulcerative colitis
#184Methods of treating inflammatory and autoimmune diseases with natalizumab
#185Systems and methods for diagnosing and/or monitoring disease
#186Patient-specific biomarkers of invasion in inflammatory bowel disease
#187Methods of diagnosing inflammatory bowel disease through RNASET2
#188Detection method using eukaryotic cells
#189Compositions and methods to detect gastrointestinal disease
#190IBS sensitivity testing
#191Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
#192TREATMENT OF INFLAMMATORY BOWEL DISEASE
#193Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#194METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE
#195COMPOSITIONS AND METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES
#196Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
#197Complex-specific standardization of immunological methods for the quantification of S100A12
#198Antibody to cytolethal distending toxin of Campylobacter jejuni
#199Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
#200COMPOSITIONS, DEVICES, AND METHODS OF CROHN'S DISEASE SENSITIVITY TESTING
#201COMPOSITIONS, DEVICES, AND METHODS OF ULCERATIVE COLITIS SENSITIVITY TESTING
#202Method and apparatus for monitoring state of inflammatory bowel disease
#203Screening and culture method
#204Method of distinguishing constipation predominant IBS from inflammatory bowel syndrome by analysis of methane concentration
#205Diagnosis and treatment of autoimmune diseases
#206METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#207Infiltrating immune cell proportions predict anti-TNF response in colon biopsies
#208IL-22BP AS BIOMARKER IN ANTI-TNF-ALPHA-TREATMENTS
#209Treatments for Gastrointestinal Disorders
#210Methods of disease activity profiling for personalized therapy management
#211METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE-RELATED DISEASES OR DISORDERS AND/OR THERAPY MONITORING
#212Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease
#213Method of measuring a level of anti-vinculin antibodies in a biological sample
#214Materials and methods for determining cancer risk
#215Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#216Method for determining fat free body mass
#217CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease
#218Methods for diagnosing and treating inflammatory bowel disease
#219Compositions and methods to detect non-coeliac gluten sensitivity
#220Pathway specific markers for diagnosing irritable bowel syndrome
#221Methods for the diagnosis and treatment of inflammatory bowel disease
#222ERBB4 activator screening assay
#223Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease
#224Anti-methanogenic lovastatin analogs or derivatives and uses thereof
#225Markers for inflammatory bowel disease
#226Dosage regimen for MAdCAM antagonists
#227Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers
#228Pharmaceutical compositions for preventing or treating inflammatory bowel diseases
#229Detection of serum anti-FadA antibodies and related diagnostic methods
#230Fluid actuation of instruments through a sterile barrier
#231Antibody to cytolethal distending toxin of
#232Methods for detecting novel autoantibodies in Crohn's disease
#233METABOLIC BIOMARKERS OF CROHN'S DISEASE
#234Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
#235Method of determinig levels of anti-vinculin and anti-cytolethal distending toxin antibodies in subjects desiring to distinguish irritable bowel syndrome from inflammatory bowel disease
#236Treatments for Gastrointestinal Disorders
#237Methods for treating inflammatory bowel disease
#238Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases
#239Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#240PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS
#241Methods for Monitoring Responsiveness to Anti-SMAD7 Therapy
#242TRANSCUTANEOUS ORGAN FUNCTION MEASUREMENT
#243METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISORDERS
#244Biomarker for mental disease
#245Method for detecting anti-vinculin antibodies in a subject with an IBS symptom
#246Methods and products for evaluating an immune response to a therapeutic protein
#247Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#248Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#249Treating conditions associated with metabolic syndrome
#250METHODS OF DETECTING INFLAMMATORY MARKERS AND TREATING INFLAMMATORY CONDITIONS IN HUMANS
#251Treating mental disorders
#252Treating cancer
#253Treating conditions associated with sepsis
#254Treating respiratory conditions
#255Treating multiple sclerosis
#256Semaphorin 3A for treatment and assessment of severity of inflammatory bowel disease
#257PREDICTIVE MARKERS OF IBD
#258Method for treating chronic intestinal inflammation and inflammatory bowel disease by administering antagonists of Oncostatin-M (OSM) and/or antagonists of OSM receptor-beta (OSMR)
#259Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#260Methods for evaluation of the effectiveness of a drug or drug candidate in treating an inflammatory bowel disease by use of multiplexed assay kit comprising various biomarkers
#261EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#262Method for determining the distinctive nutritional requirements of a patient
#263DIAGNOSTIC MARKERS FOR CROHN'S DISEASE
#264Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
#265Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#266Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor
#267Vedolizumab for the Treatment of Fistulizing Crohn's Disease
#268Compositions, devices, and methods of IBS sensitivity testing
#269Methods for prediction of anti-TNFα drug levels and autoantibody formation
#270Pathway specific markers for diagnosing irritable bowel syndrome
#271METHOD AND KIT FOR THE PREDICTIVE PROGNOSIS OF RESPONSIVENESS TO TREATMENTS OF AUTOIMMUNE DISEASES
#272Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
#273Methods, agents and compositions for treatment of inflammatory conditions
#274Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
#275COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#276Methods of treating inflammatory and autoimmune diseases with natalizumab
#277METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#278Markers for inflammatory bowel disease
#279CEACAM5 PEPTIDES FOR CROHN'S DISEASE
#280Methods for treating medical conditions by anti-type 2 therapy
#281METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE
#282DETECTING GLUTEN PEPTIDES IN HUMAN FLUIDS
#283Peptide, magnetic peptide and method for detecting celiac disease
#284METHODS AND COMPOSITIONS FOR ASSESSING PREDICTING RESPONSIVENESS TO A TNF INHIBITOR
#285Transcutaneous organ function measurement
#286USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#287Microbiomarker for Celiac Disease and a Related Product
#288Treatment or prevention of an intestinal disease or disorder
#289METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#290Biomarker for diagnosis of irritable bowel syndrome
#291COMPOSITIONS AND METHODS FOR TREATING SUBJECTS WITH IMMUNE-MEDIATED DISEASES
#292ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 Receptor
#293Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome
#294SELENIUM AND SELENIUM-DEPENDENT MOLECULES PREDICT PRESENCE OF MYCOBACTERIA
#295Biomarker panel for assessment of mucosal healing
#296Methods and apparatus for detection of gluten sensitivity, and its differentiation from celiac disease
#297Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders
#298Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#299SIGNALING PATHWAYS IN TISSUES FROM INFLAMMATORY BOWEL DISEASE PATIENTS
#300METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF CROHN'S DISEASE